Résultats de la recherche - Saw, Robyn
- Résultat(s) 1 - 20 résultats de 36
- Aller à la page suivante
-
1
-
2
Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D) par Saw, Robyn PM, Armstrong, Bruce K, Mason, Rebecca S, Morton, Rachael L, Shannon, Kerwin F, Spillane, Andrew J, Stretch, Jonathan R, Thompson, John F
Publié 2014Texte -
3
Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review par Blood, Zachary, Tran, Anh, Caleo, Lauren, Saw, Robyn, Dieng, Mbathio, Shackleton, Mark, Soyer, H Peter, Arnold, Chris, Mann, Graham J, Morton, Rachael L
Publié 2021Texte -
4
Primary and metastatic cutaneous melanomas express ALK through alternative transcriptional initiation par Busam, Klaus J., Villain, Ricardo E., Lum, Trina, Busam, Jonathan A., Hollmann, Travis J., P.M.Saw, Robyn, Coit, Daniel C., Scolyer, Richard A., Wiesner, Thomas
Publié 2016Texte -
5
Current management of patients with melanoma who are found to be sentinel node‐positive par Nijhuis, Amanda A. G., Spillane, Andrew J., Stretch, Jonathan R., Saw, Robyn P. M., Menzies, Alexander M., Uren, Roger F., Thompson, John F., Nieweg, Omgo E.
Publié 2019Texte -
6
Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma par Dieng, Mbathio, Turner, Robin M., Lord, Sarah J., Einstein, Andrew J., Menzies, Alexander M., Saw, Robyn P. M., Nieweg, Omgo E., Thompson, John F., Morton, Rachael L.
Publié 2022Texte -
7
Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol par Dieng, Mbathio, Khanna, Nikita, Nguyen, Mai Thi Hoang, Turner, Robin, Lord, Sarah J, Menzies, Alexander M, Allen, Jay, Saw, Robyn, Nieweg, Omgo E, Thompson, John, Morton, Rachael L
Publié 2020Texte -
8
Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA par Diefenbach, Russell J., Lee, Jenny H., Stewart, Ashleigh, Menzies, Alexander M., Carlino, Matteo S., Saw, Robyn P. M., Stretch, Jonathan R., Long, Georgina V., Scolyer, Richard A., Rizos, Helen
Publié 2022Texte -
9
Staging (18)F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases par Holtkamp, Lodewijka H.J., Chakera, Annette H., Fung, Sebastian, Stretch, Jonathan R., Saw, Robyn P.M., Lee, Kenneth, Ch’ng, Sydney, Gonzalez, Maria, Thompson, John F., Emmett, Louise, Nieweg, Omgo E.
Publié 2020Texte -
10
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients par Gide, Tuba N., Silva, Ines P., Quek, Camelia, Ahmed, Tasnia, Menzies, Alexander M., Carlino, Matteo S., Saw, Robyn P.M., Thompson, John F., Batten, Marcel, Long, Georgina V., Scolyer, Richard A., Wilmott, James S.
Publié 2019Texte -
11
Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA par Diefenbach, Russell J., Lee, Jenny H., Menzies, Alexander M., Carlino, Matteo S., Long, Georgina V., Saw, Robyn P. M., Howle, Julie R., Spillane, Andrew J., Scolyer, Richard A., Kefford, Richard F., Rizos, Helen
Publié 2020Texte -
12
The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma par Dieng, Mbathio, Lord, Sarah J., Turner, Robin M., Nieweg, Omgo E., Menzies, Alexander M., Saw, Robyn P. M., Einstein, Andrew J., Emmett, Louise, Thompson, John F., Lo, Serigne N., Morton, Rachael L.
Publié 2022Texte -
13
Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma par Pennington, Thomas E, Zhao, Cathy Yunjia, Colebatch, Andrew J, Fernandez‐Peñas, Pablo, Guitera, Pascale, Burke, Hazel, Scolyer, Richard A, Menzies, Alexander M, Carlino, Matteo S, Lo, Serigne, Long, Georgina V, Saw, Robyn PM
Publié 2022Texte -
14
Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma par Lim, Wei-Yin, Morton, Rachael L., Turner, Robin M., Jenkins, Marisa C., Guitera, Pascale, Irwig, Les, Webster, Angela C., Dieng, Mbathio, Saw, Robyn P. M., Low, Donald, Low, Cynthia, Bell, Katy J. L.
Publié 2018Texte -
15
Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma par Lim, Wei-Yin, Turner, Robin M., Morton, Rachael L., Jenkins, Marisa C., Irwig, Les, Webster, Angela C., Dieng, Mbathio, Saw, Robyn P. M., Guitera, Pascale, Low, Donald, Low, Cynthia, Bell, Katy J. L.
Publié 2018Texte -
16
Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0–II) melanoma par Thompson, Jake R, Smith, Andrea L, Lo, Serigne N, Kasparian, Nadine A, Saw, Robyn PM, Dieng, Mbathio, Seaman, Linda, Martin, Linda K, Guitera, Pascale, Milne, Donna, Schmid, Helen, Cust, Anne E, Bartula, Iris
Publié 2022Texte -
17
Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas par Quek, Camelia, Rawson, Robert V., Ferguson, Peter M., Shang, Ping, Silva, Ines, Saw, Robyn P.M., Shannon, Kerwin, Thompson, John F., Hayward, Nicholas K., Long, Georgina V., Mann, Graham J., Scolyer, Richard A., Wilmott, James S.
Publié 2019Texte -
18
Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management par Doubrovsky, Anna, Scolyer, Richard A., Murali, Rajmohan, McKenzie, Paul R., Watson, Geoffrey F., Lee, C. Soon, McLeod, Duncan J., McCarthy, William H., Uren, Roger F., Stretch, Jonathan R., Saw, Robyn P., Thompson, John F.
Publié 2007Texte -
19
Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma par Shklovskaya, Elena, Lee, Jenny H, Lim, Su Yin, Stewart, Ashleigh, Pedersen, Bernadette, Ferguson, Peter, Saw, Robyn PM, Thompson, John F, Shivalingam, Brindha, Carlino, Matteo S, Scolyer, Richard A, Menzies, Alexander M, Long, Georgina V, Kefford, Richard F, Rizos, Helen
Publié 2020Texte -
20
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets par Gide, Tuba N., Pires da Silva, Inês, Quek, Camelia, Ferguson, Peter M., Batten, Marcel, Shang, Ping, Ahmed, Tasnia, Menzies, Alexander M., Carlino, Matteo S., Saw, Robyn P. M., Thompson, John F., Scolyer, Richard A., Long, Georgina V., Wilmott, James S.
Publié 2021Texte